PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1529589
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1529589
The global biosensors market is estimated to be valued at USD 29.50 Bn in 2024 and is expected to reach USD 55.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.3% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | US$ 29.50 Bn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
Forecast Period 2024 to 2031 CAGR: | 9.30% | 2031 Value Projection: | US$ 55.10 Bn |
The global biosensors market has garnered substantial momentum in recent years owing to its widespread applications across diverse industries. Biosensors have emerged as an effective analytical tool for detecting analytes that are biologically significant. They provide accurate, fast and sensitive measurements by integrating a biological component with a physicochemical detector. Advancements in nanotechnology and microfabrication techniques have played a crucial role in miniaturizing biosensors and enabling point-of-care testing. The growing prevalence of chronic and infectious diseases has augmented the demand for continuous health monitoring solutions using portable biosensing devices. Moreover, biosensors find extensive use in food safety testing, bioprocess monitoring, and environmental monitoring. The industrial demand for biosensors is expected to grow further with advancements in wearable technologies and mobile health applications.
The global biosensors market is driven by the rising geriatric population, growing prevalence of chronic diseases, increasing demand for point-of-care testing, and continuous health monitoring. According to the United Nations, by 2050, over 16% of the global population will be aged 65 and above. This expands the risk of diseases and disorders requiring long-term health monitoring using biosensors. Favorable government initiatives and funding for biosensor research offer lucrative opportunities for market players. However, limitations regarding the stability, reproducibility and shelf life of biosensors remain a major challenge. Stringent regulatory frameworks for the approval of biosensing devices also restrains the market growth. On the other hand, promising opportunities lie in the development of wearable, minimally invasive, and cost-effective biosensors for patient-centric care and overall wellness management.
Detailed Segmentation-